The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)

Annals of the Rheumatic Diseases

Volumn 72, Issue 6, 2013, Pages 986-991

  Helliwell, Philip S ^a,b   FitzGerald, Oliver ^c   Fransen, Jaap ^d   Gladman, Dafna D ^e   Kreuger, Gerald G ^f   Callis Duffin, Kristina ^f   McHugh, Neil ^g   Mease, Philip J ^h   Strand, Vibeke ⁱ   Waxman, Robin ^a   Azevedo, Valderilio Feijo ^j   Ostos, Adriana Beltran ^k   Carneiro, Sueli ^l   Cauli, Alberto ^m   Espinoza, Luis R ⁿ   Flynn, John A ^o   Hassan, Nada ^p   Healy, Paul ^q   Kerzberg, Eduardo Mario ^r   Lee, Yun Jong ^s   Lubrano, Ennio ^t   Marchesoni, Antonio ^u   Marzo Ortega, Helena ^a   Porru, Giovanni ^v   Moreta, Elvia G ^w   Nash, Peter ^x   Raffayova, Helena ^y   Ranza, Roberto ^z   Raychaudhuri, Siba P ^aa   Roussou, Euthalia ^ab   Scarpa, Raphael ^ac   Song, Yeong Wook ^ad   Soriano, Enrique R ^ae   Tak, Paul P ^af   Ujfalussy, Ilona ^ag   De Vlam, Kurt ^ah   Walsh, Jessica A ^f   more..

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^k Clinical Rheumatology   (Colombia)

^l FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^m UNIVERSITY OF CAGLIARI   (Italy)

ⁿ LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^o JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p SOUTHEND UNIVERSITY HOSPITAL   (United Kingdom)

^q Hutt Valley District Health Board   (New Zealand)

^r UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^s Seoul National University Bundang Hospital   (South Korea)

^t UNIVERSITY OF MOLISE   (Italy)

^u ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^v UNIVERSITY OF CAGLIARI   (Italy)

^w St Paul Rheumatology ^*  (United States)

^x UNIVERSITY OF QUEENSLAND   (Australia)

^y NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

^z FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^aa UNIVERSITY OF CALIFORNIA   (United States)

^ab HAVERING AND REDBRIDGE UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^ac UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^ad Seoul National University Hospital   (South Korea)

^ae HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^af UNIVERSITY OF AMSTERDAM   (Netherlands)

^ag Military Hospital National Health Center   (Hungary)

^ah UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTHRITIS; ARTICLE; CLINICAL ASSESSMENT TOOL; COMPOSITE PSORIATIC ARTHRITIS DISEASE ACTIVITY INDEX; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; DISEASE ACTIVITY FOR PSORIATIC ARTHRITIS; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PSORIATIC ARTHRITIS DISEASE ACTIVITY SCORE; SCORING SYSTEM;

EID: 84877636515     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201341     Document Type: Article

References (28)

1. Clegg DO, Reda DJ, Mejias E, et al. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthr Rheum 1996;39:2013-20.
2. Antoni C, Krueger GG, de Vlam K, et al. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005;64:1150-7. (Pubitemid 41113349)
3. Mease PJ, Goffe BS, Metz J, et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.[see comment]. Lancet 2000;356:385-90. (Pubitemid 30487495)
4. Mumtaz A, Gallagher P, Kirby B, et al. Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis 2011;70:272-7.
5. Helliwell PS, Fitzgerald O, Strand V, et al. Composite measures in psoriatic arthritis. Report from the GRAPPA 2009 annual meeting. J Rheumatol 2011;38:540-5.
6. Eberl G, Studnicka-Benke A, Hitzelhammer H, et al. Development of a disease activity index for the assessment of reactive arthritis (DAREA). Rheumatology 2000;39:148-55. (Pubitemid 30139347)
7. Nell-Duxneuner VP, Stamm TA, Machold KP, et al. Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis. Ann Rheum Dis 2010;69:546-9.
8. FitzGerald O, Helliwell P, Mease P, et al. Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set. Ann Rheum Dis 2012;71:358-62.
9. Prevoo M, van Gestel A, van t'Hof MH, et al. Remission in a proposed study of patients with rheumatoid arthritis. American Rheumatism Association preliminary criteria in relation to the disease activity score. Rheumatology 1996;35:1101-5.
10. van Gestel AM, Prevoo ML, Van't Hof MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthr Rheum 1996;39:34-40. (Pubitemid 26036375)
11. Gladman DD, Mease PJ, Strand V, et al. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007;34:1167-70. (Pubitemid 46774868)
12. Lukas C, Landewe R, Sieper J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:18-24.
13. Fransen J, Kavanaugh A, Borm G. Desirability scores for assessing multiple outcomes in systemic rheumatic diseases. Commun Stat Theory Methods 2009;38:3461-71.
14. Coates LC, Fransen J, Helliwell PS. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 2010;69:48-53.
15. Jenkinson TR, Mallorie PA, Whitelock HC, et al. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994;21:1694-8. (Pubitemid 24285485)
16. Fredricksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978;157:238-44. (Pubitemid 8387357)
17. Cassell SE, Bieber JD, Rich P, et al. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol 2007;34:123-9. (Pubitemid 46106572)
18. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003;62:127-32. (Pubitemid 36135387)
19. Healy P, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific for psoriatic arthritis. Arthr Care Res 2008;59:686-91. (Pubitemid 351679544)
20. Maksymowych WP, Mallon C, Morrow S, et al. Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis index. Ann Rheum Dis 2009;68:948-53.
21. Finlay AY. Quality of life assessments in dermatology. Semin Cutan Med Surg 1998;17:291-6. (Pubitemid 28555135)
22. Doward LC, Spoorenberg A, Cook SA, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003;62:20-6. (Pubitemid 36005790)
23. McKenna SP, Doward LC, Whalley D, et al. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 2004;63:162-9. (Pubitemid 38122135)
24. Ware JE. Measuring patients' views: the optimum outcome measure. BMJ 1993;306:1429-30. (Pubitemid 23154744)
25. Fries JF, Spitz P, Kraines RG, et al. Measurement of patient outcome in arthritis. Arthr Rheum 1980;23:137-45. (Pubitemid 10164318)
26. Chandran V, Gottlieb A, Cook RJ, et al. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthr Rheum 2009;61:1235-42.
27. Boers M, Brooks P, Strand CV, et al. The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol 1998;25:198-9.
28. Cauli A, Gladman DD, Mathieu A, et al. Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study. J Rheumatol 2011;38:898-903.